Ticker > Company >

Neochem Bio Solution share price

Neochem Bio Solutions Ltd.

  3.11 K   1   0 NSE: NEOCHEM SECTOR: Chemicals

111.45
+1.85 (1.69%)
NSE: 16 Oct 03:54 PM

Price Summary

Today's High

₹ 112.35

Today's Low

₹ 108

52 Week High

₹ 121

52 Week Low

₹ 63

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 190.81 Cr.

Enterprise Value

₹ 208.42 Cr.

No. of Shares

1.71 Cr.

P/E

15.87

P/B

2.42

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  46.05

CASH

₹ 0.18 Cr.

DEBT

₹ 17.79 Cr.

Promoter Holding

66.88 %

EPS (TTM)

₹  7.02

Sales Growth

31.51%

ROE

24.4 %

ROCE

27.22%

Profit Growth

61.64 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year31.51%
3 Year31.95%
5 YearNA

Profit Growth

1 Year61.64%
3 Year119.28%
5 YearNA

ROE%

1 Year24.4%
3 Year29.81%
5 Year26.29%

ROCE %

1 Year27.22%
3 Year22.75%
5 Year17.9%

Debt/Equity

0.2257

Price to Cash Flow

-11.27

Interest Cover Ratio

5.902

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2026 66.88 0.00
Mar 2026 66.72 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 31.9470931430045% for the Past 3 years.
  • The company has significantly decreased its debt by 17.8311 Cr.
  • Company has been maintaining healthy ROE of 29.8078333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 22.7459% over the past 3 years.
  • Company has a healthy liquidity position with current ratio of 2.3941.
  • The company has a high promoter holding of 66.88%.
  • Promoter stake has increased from 0% to 66.72% in the last 1 quarter.

 Limitations

  • Company has negative cash flow from operations of -16.9378.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 48.6 48.19 61.15 84.17 110.7
Total Expenditure 45.08 43.89 55.02 71.37 90.85
Operating Profit 3.51 4.29 6.12 12.8 19.85
Other Income 0.09 0.6 0.86 1.98 2.7
Interest 1.28 2.1 2.96 3.51 3.51
Depreciation 1.04 1.22 1.22 1.33 1.24
Exceptional Items 0 0 0 0 -0.62
Profit Before Tax 1.28 1.59 2.8 9.95 17.18
Tax 0.31 0.45 0.88 2.51 5.16
Net Profit 0.97 1.14 1.93 7.44 12.03
Adjusted EPS (Rs.) 1.85 1.2 1.65 6.37 7.02

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 3 5.43 6.68 6.68 17.12
Total Reserves 1.09 2.96 5.64 13.08 61.72
Borrowings 15.1 12.33 18.12 14.28 0.7
Other N/C liabilities 0.72 0.74 0.74 0.91 1.69
Current liabilities 26.47 29.21 32.29 43.95 35.89
Total Liabilities 46.38 50.67 63.46 78.89 117.12
Assets
Net Block 12.44 14.67 18.81 18.67 19.93
Capital WIP 0.15 0.04 0.03 0.06 0.06
Intangible WIP 0 0 0 0 0
Investments 0.09 0.09 0 0 6.25
Loans & Advances 0.79 0.35 3.33 2.82 0.25
Other N/C Assets 3.79 3.79 3.7 4.27 4.71
Current Assets 29.12 31.72 37.59 53.08 85.92
Total Assets 46.38 50.67 63.46 78.89 117.12
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 0.97 1.14 1.93 9.95 17.18
Adjustment 2.3 3.32 4.19 4.75 4.66
Changes in Assets & Liabilities -4.53 -5.43 -6.74 -11.79 -35.82
Tax Paid -0.2 0 0 -0.87 -2.96
Operating Cash Flow -1.46 -0.97 -0.63 2.04 -16.94
Investing Cash Flow -2.74 -3.32 -5.26 -1.13 -8.67
Financing Cash Flow 4.33 3.95 6.2 -1.2 25.73
Net Cash Flow 0.12 -0.34 0.3 -0.3 0.13

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2026

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY26
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q3FY26
Presentation Q1FY27
Presentation Q1FY27

Company News

Neochem Bio Solution Stock Price Analysis and Quick Research Report. Is Neochem Bio Solution an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Neochem Bio Solution. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Neochem Bio Solution has a PE ratio of 15.8656720667369 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Neochem Bio Solution has ROA of 12.2716% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Neochem Bio Solution has a Current ratio of 2.3941.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Neochem Bio Solution has a ROE of 24.3953%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Neochem Bio Solution has a Debt to Equity ratio of 0.2257 which means that the company has low proportion of debt in its capital.

  • Sales growth: Neochem Bio Solution has reported revenue growth of 31.5146% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Neochem Bio Solution for the current financial year is 17.9327078556885%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Neochem Bio Solution is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Neochem Bio Solution is Rs 7.0246. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Neochem Bio Solution in Ticker for free. Also, one can get the intrinsic value of Neochem Bio Solution by using Valuation Calculators, which are available with a Finology ONE subscription. 

Neochem Bio Solution FAQs

Q1. What is Neochem Bio Solution share price today?
Ans: The current share price of Neochem Bio Solution is Rs 111.45.

Q2. What is the market capitalisation of Neochem Bio Solution?
Ans: Neochem Bio Solution has a market capitalisation of Rs 190.810792185 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Neochem Bio Solution?
Ans: The PE ratio of Neochem Bio Solution is 15.8656720667369 and the P/B ratio of Neochem Bio Solution is 2.42007982246234, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Neochem Bio Solution share?
Ans: The 52-week high share price of Neochem Bio Solution is Rs 121, and the 52-week low share price of Neochem Bio Solution is Rs 63.

Q5. Does Neochem Bio Solution pay dividends?
Ans: Currently, Neochem Bio Solution does not pay dividends. Dividend yield of Neochem Bio Solution is around 0%.

Q6. What are the face value and book value of Neochem Bio Solution shares?
Ans: The face value of Neochem Bio Solution shares is Rs 10, while the book value per share of Neochem Bio Solution is around Rs 46.0522. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Neochem Bio Solution?
Ans: Neochem Bio Solution has a total debt of Rs 17.7935 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Neochem Bio Solution?
Ans: The ROE of Neochem Bio Solution is 24.3953% and ROCE of Neochem Bio Solution is 27.2179%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Neochem Bio Solution a good buy for the long term?
Ans: The Neochem Bio Solution long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Neochem Bio Solution undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Neochem Bio Solution appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Neochem Bio Solution’s financials?
Ans: You can review Neochem Bio Solution’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Neochem Bio Solution
X